<DOC>
	<DOCNO>NCT00935220</DOCNO>
	<brief_summary>The objective trial investigate pharmacokinetics pharmacodynamics linagliptin ( BI 1356 ) 5 mg administer orally patient Type 2 diabetes mellitus African American origin .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Trial With Linagliptin ( BI 1356 ) 5mg African American Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Inclusion criterion : 1 . Glycosylated haemoglobin &gt; =7 &lt; = 10 % 2 . Age &gt; =21 &lt; = 65 3 . Body Mass Index &gt; =18.5 &lt; =38 kg/m2 4 . African American origin 5 . Signed date informed consent prior admission study Exclusion criterion : 1 . Any finding medical examination consider clinically relevant Investigator 2 . Clinically relevant concomitant disease like renal insufficiency , cardiac insufficiency New York Heart Association ( NYHA ) IIIV , know cardiovascular disease include hypertension &gt; 160100 mmHg ( current treatment ) , stroke transient ischemic attack ( TIA ) . 3 . Clinically relevant gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder besides type 2 diabetes 4 . Clinically relevant diseases central nervous system psychiatric disorder relevant neurological disorder besides polyneuropathy 5 . Diagnosis sickle cell anemia know chronic anemia 6 . History chronic relevant infection ( example human immunodeficieny virus ( HIV ) , Hepatitis B ) 7 . History relevant allergy/hypersensitivity 8 . Intake drug long half life ( &gt; 24hours ) within least one month less 10 half life respective drug prior administration except allow co medication 9 . Alcohol abuse , drug abuse 10 . Any laboratory value clinical relevance outside acceptable range 11 . Change drug dosing allow co medication 12 . Any ( electrocardiogram ) ECG value outside reference range clinical relevance . 13 . Fasted glucose &gt; 270 mg/dl randomly determine blood glucose &gt; 400 mg/dl two consecutive day screen wash 14 . Serum creatinine upper limit normal screening</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>